Lista de obras - Audrey GABELLE - Dominio Público Uruguay

A Complex Relationship Between Suicide, Dementia, and Amyloid: A Narrative Review.

artículo científico publicado en 2018

A diagnostic scale for Alzheimer's disease based on cerebrospinal fluid biomarker profiles

artículo científico publicado en 2014

A meta-analysis of human embryonic stem cells transcriptome integrated into a web-based expression atlas.

artículo científico publicado en 2007

A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease

artículo científico publicado en 2020

Absolute quantification of 35 plasma biomarkers in human saliva using targeted MS

artículo científico publicado en 2015

Alzheimer's Disease: Advances in Drug Development

artículo científico publicado en 2018

Alzheimer's disease cerebro-spinal fluid biomarkers: A clinical research tool sometimes useful in daily clinical practice of memory clinics for the diagnosis of complex cases

artículo científico publicado en 2016

Amyloid imaging in Alzheimer's disease: a literature review.

artículo científico

Analytical challenges related to the use of biomarker ratios for the biological diagnosis of Alzheimer's disease.

artículo científico publicado en 2015

Antibody-free quantification of seven tau peptides in human CSF using targeted mass spectrometry.

artículo científico publicado en 2015

Anxiety and 10-Year Risk of Incident Dementia-An Association Shaped by Depressive Symptoms: Results of the Prospective Three-City Study.

artículo científico publicado en 2018

Are migraine and non-migrainous headache risk factors for stroke in the elderly? Findings from a 12-year cohort follow-up

artículo científico publicado en 2016

Association between serum hepcidin level and restless legs syndrome

artículo científico publicado en 2018

Association of Long-Term Diet Quality with Hippocampal Volume: Longitudinal Cohort Study

artículo científico publicado en 2018

Autoantibody profiling on high-density protein microarrays for biomarker discovery in the cerebrospinal fluid

scientific article published on 24 July 2008

Biomarkers of Alzheimer's disease: the present and the future.

artículo científico

Can event-related potential predict the progression of mild cognitive impairment?

artículo científico publicado en 2011

Can we rely only on ratios of cerebrospinal fluid biomarkers for AD biological diagnosis?

artículo científico publicado en 2014

Central Nervous System and Peripheral Inflammatory Processes in Alzheimer's Disease: Biomarker Profiling Approach.

artículo científico publicado en 2015

Cerebrospinal Fluid Alzheimer's Disease Biomarkers in Cerebral Amyloid Angiopathy-Related Inflammation.

artículo científico publicado en 2016

Cerebrospinal Fluid Alzheimer's Disease Biomarkers in Isolated Supratentorial Cortical Superficial Siderosis.

artículo científico publicado en 2016

Cerebrospinal fluid Alzheimer biomarkers can be useful for discriminating dementia with Lewy bodies from Alzheimer's disease at the prodromal stage.

artículo científico publicado en 2018

Cerebrospinal fluid amyloid-β 42/40 ratio in clinical setting of memory centers: a multicentric study

artículo científico publicado en 2015

Cerebrospinal fluid levels of orexin-A and histamine, and sleep profile within the Alzheimer process.

artículo científico publicado en 2017

Cognitive Event-Related Potential, an Early Diagnosis Biomarker in Frail Elderly Subjects: The ERP-MAPT-PLUS Ancillary Study.

artículo científico publicado en 2017

Decreased sAβPPβ, Aβ38, and Aβ40 cerebrospinal fluid levels in frontotemporal dementia.

artículo científico publicado en 2011

Demographic, neurological and behavioural characteristics and brain perfusion SPECT in frontal variant of frontotemporal dementia.

artículo científico publicado en 2006

Development and validation of dried matrix spot sampling for the quantitative determination of amyloid β peptides in cerebrospinal fluid.

artículo científico publicado en 2014

Development of new quantitative mass spectrometry and semi-automatic isofocusing methods for the determination of Apolipoprotein E typing.

artículo científico publicado en 2015

Differential Mass Spectrometry Profiles of Tau Protein in the Cerebrospinal Fluid of Patients with Alzheimer's Disease, Progressive Supranuclear Palsy, and Dementia with Lewy Bodies.

artículo científico publicado en 2016

Editorial: Collaborative Efforts to Prevent Alzheimer's Disease

artículo científico publicado en 2017

Excessive Sleepiness and Longer Nighttime in Bed Increase the Risk of Cognitive Decline in Frail Elderly Subjects: The MAPT-Sleep Study

artículo científico publicado en 2017

From radioimmunoassay to mass spectrometry: a new method to quantify orexin-A (hypocretin-1) in cerebrospinal fluid.

artículo científico publicado en 2016

Generation of induced pluripotent stem cells (IRMBi001-A) from an Alzheimer's disease patient carrying a G217D mutation in the PSEN1 gene

scientific article published on 03 January 2019

HIV Neuroinfection and Alzheimer's Disease: Similarities and Potential Links?

article

How to optimize the use of biobanks from population-based cohorts in aging research.

artículo científico publicado en 2015

Hypocretin and brain β-amyloid peptide interactions in cognitive disorders and narcolepsy.

artículo científico publicado en 2014

Identification of multiple proteoforms biomarkers on clinical samples by routine Top-Down approaches.

artículo científico publicado en 2018

Impact of cerebro-spinal fluid biomarkers of Alzheimer's disease in clinical practice: a multicentric study.

artículo científico publicado en 2013

Impact of harmonization of collection tubes on Alzheimer's disease diagnosis.

artículo científico publicado en 2013

Influence of activity space on the association between neighborhood characteristics and dementia risk: results from the 3-City study cohort

artículo científico publicado en 2019

Intake of Meat, Fish, Fruits, and Vegetables and Long-Term Risk of Dementia and Alzheimer's Disease

artículo científico publicado en 2019

Neurodegenerative dementia and parkinsonism.

artículo científico publicado en 2010

Palmomental Reflex a Relevant Sign in Early Alzheimer's Disease Diagnosis?

artículo científico publicado en 2015

Pathogenic p62/SQSTM1 mutations impair energy metabolism through limitation of mitochondrial substrates.

artículo científico publicado en 2017

Plasma β-amyloid 40 levels are positively associated with mortality risks in the elderly.

artículo científico publicado en 2014

Predicting dementia using socio-demographic characteristics and the Free and Cued Selective Reminding Test in the general population.

artículo científico publicado en 2017

Primary Progressive Aphasia in the Network of French Alzheimer Plan Memory Centers

artículo científico

Prion replication occurs in endogenous adult neural stem cells and alters their neuronal fate: involvement of endogenous neural stem cells in prion diseases

artículo científico publicado en 2013

Quantification of hepcidin-25 in human cerebrospinal fluid using LC-MS/MS.

artículo científico publicado en 2017

Quantitative detection of amyloid-β peptides by mass spectrometry: state of the art and clinical applications

artículo científico publicado en 2015

Relevance of Aβ42/40 Ratio for Detection of Alzheimer Disease Pathology in Clinical Routine: The PLMR Scale.

artículo científico publicado en 2018

Risk of Alzheimer's Disease Biological Misdiagnosis Linked to Cerebrospinal Collection Tubes

artículo científico publicado en 2012

SILK studies - capturing the turnover of proteins linked to neurodegenerative diseases

scientific article published on 20 June 2019

Sensory-motor neuropathy: a slow and misleading case of leprosy

artículo científico publicado en 2008

Sex-specific association between neighborhood characteristics and dementia: The Three-City cohort

artículo científico publicado en 2017

Somatostatin and Neuropeptide Y in Cerebrospinal Fluid: Correlations With Amyloid Peptides Aβ and Tau Proteins in Elderly Patients With Mild Cognitive Impairment

artículo científico publicado en 2018

Stable Isotope Labeling by Amino acid in Vivo (SILAV): a new method to explore protein metabolism.

artículo científico publicado en 2015

Systemic delivery of siRNA down regulates brain prion protein and ameliorates neuropathology in prion disorder.

artículo científico publicado en 2014

Tau Protein Quantification in Human Cerebrospinal Fluid by Targeted Mass Spectrometry at High Sequence Coverage Provides Insights into Its Primary Structure Heterogeneity.

artículo científico publicado en 2016

The prognostic value of the Tau protein serum level in metastatic breast cancer patients and its correlation with brain metastases

artículo científico publicado en 2019

Towards a routine application of Top-Down approaches for label-free discovery workflows

artículo científico publicado en 2017

[CSF biomarkers: proteomics investigations and clinical applications in neurodegenerative disorders]

artículo científico publicado en 2008

Lista de obras de Audrey GABELLE

A Complex Relationship Between Suicide, Dementia, and Amyloid: A Narrative Review.

A diagnostic scale for Alzheimer's disease based on cerebrospinal fluid biomarker profiles

A meta-analysis of human embryonic stem cells transcriptome integrated into a web-based expression atlas.

A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease

Absolute quantification of 35 plasma biomarkers in human saliva using targeted MS

Alzheimer's Disease: Advances in Drug Development

Alzheimer's disease cerebro-spinal fluid biomarkers: A clinical research tool sometimes useful in daily clinical practice of memory clinics for the diagnosis of complex cases

Amyloid imaging in Alzheimer's disease: a literature review.

Analytical challenges related to the use of biomarker ratios for the biological diagnosis of Alzheimer's disease.

Antibody-free quantification of seven tau peptides in human CSF using targeted mass spectrometry.

Anxiety and 10-Year Risk of Incident Dementia-An Association Shaped by Depressive Symptoms: Results of the Prospective Three-City Study.

Are migraine and non-migrainous headache risk factors for stroke in the elderly? Findings from a 12-year cohort follow-up

Association between serum hepcidin level and restless legs syndrome

Association of Long-Term Diet Quality with Hippocampal Volume: Longitudinal Cohort Study

Autoantibody profiling on high-density protein microarrays for biomarker discovery in the cerebrospinal fluid

Biomarkers of Alzheimer's disease: the present and the future.

Can event-related potential predict the progression of mild cognitive impairment?

Can we rely only on ratios of cerebrospinal fluid biomarkers for AD biological diagnosis?

Central Nervous System and Peripheral Inflammatory Processes in Alzheimer's Disease: Biomarker Profiling Approach.

Cerebrospinal Fluid Alzheimer's Disease Biomarkers in Cerebral Amyloid Angiopathy-Related Inflammation.

Cerebrospinal Fluid Alzheimer's Disease Biomarkers in Isolated Supratentorial Cortical Superficial Siderosis.

Cerebrospinal fluid Alzheimer biomarkers can be useful for discriminating dementia with Lewy bodies from Alzheimer's disease at the prodromal stage.

Cerebrospinal fluid amyloid-β 42/40 ratio in clinical setting of memory centers: a multicentric study

Cerebrospinal fluid levels of orexin-A and histamine, and sleep profile within the Alzheimer process.

Cognitive Event-Related Potential, an Early Diagnosis Biomarker in Frail Elderly Subjects: The ERP-MAPT-PLUS Ancillary Study.

Decreased sAβPPβ, Aβ38, and Aβ40 cerebrospinal fluid levels in frontotemporal dementia.

Demographic, neurological and behavioural characteristics and brain perfusion SPECT in frontal variant of frontotemporal dementia.

Development and validation of dried matrix spot sampling for the quantitative determination of amyloid β peptides in cerebrospinal fluid.

Development of new quantitative mass spectrometry and semi-automatic isofocusing methods for the determination of Apolipoprotein E typing.

Differential Mass Spectrometry Profiles of Tau Protein in the Cerebrospinal Fluid of Patients with Alzheimer's Disease, Progressive Supranuclear Palsy, and Dementia with Lewy Bodies.

Editorial: Collaborative Efforts to Prevent Alzheimer's Disease

Excessive Sleepiness and Longer Nighttime in Bed Increase the Risk of Cognitive Decline in Frail Elderly Subjects: The MAPT-Sleep Study

From radioimmunoassay to mass spectrometry: a new method to quantify orexin-A (hypocretin-1) in cerebrospinal fluid.

Generation of induced pluripotent stem cells (IRMBi001-A) from an Alzheimer's disease patient carrying a G217D mutation in the PSEN1 gene

HIV Neuroinfection and Alzheimer's Disease: Similarities and Potential Links?

How to optimize the use of biobanks from population-based cohorts in aging research.

Hypocretin and brain β-amyloid peptide interactions in cognitive disorders and narcolepsy.

Identification of multiple proteoforms biomarkers on clinical samples by routine Top-Down approaches.

Impact of cerebro-spinal fluid biomarkers of Alzheimer's disease in clinical practice: a multicentric study.

Impact of harmonization of collection tubes on Alzheimer's disease diagnosis.

Influence of activity space on the association between neighborhood characteristics and dementia risk: results from the 3-City study cohort

Intake of Meat, Fish, Fruits, and Vegetables and Long-Term Risk of Dementia and Alzheimer's Disease

Neurodegenerative dementia and parkinsonism.

Palmomental Reflex a Relevant Sign in Early Alzheimer's Disease Diagnosis?

Pathogenic p62/SQSTM1 mutations impair energy metabolism through limitation of mitochondrial substrates.

Plasma β-amyloid 40 levels are positively associated with mortality risks in the elderly.

Predicting dementia using socio-demographic characteristics and the Free and Cued Selective Reminding Test in the general population.

Primary Progressive Aphasia in the Network of French Alzheimer Plan Memory Centers

Prion replication occurs in endogenous adult neural stem cells and alters their neuronal fate: involvement of endogenous neural stem cells in prion diseases

Quantification of hepcidin-25 in human cerebrospinal fluid using LC-MS/MS.

Quantitative detection of amyloid-β peptides by mass spectrometry: state of the art and clinical applications

Relevance of Aβ42/40 Ratio for Detection of Alzheimer Disease Pathology in Clinical Routine: The PLMR Scale.

Risk of Alzheimer's Disease Biological Misdiagnosis Linked to Cerebrospinal Collection Tubes

SILK studies - capturing the turnover of proteins linked to neurodegenerative diseases

Sensory-motor neuropathy: a slow and misleading case of leprosy

Sex-specific association between neighborhood characteristics and dementia: The Three-City cohort

Somatostatin and Neuropeptide Y in Cerebrospinal Fluid: Correlations With Amyloid Peptides Aβ and Tau Proteins in Elderly Patients With Mild Cognitive Impairment

Stable Isotope Labeling by Amino acid in Vivo (SILAV): a new method to explore protein metabolism.

Systemic delivery of siRNA down regulates brain prion protein and ameliorates neuropathology in prion disorder.

Tau Protein Quantification in Human Cerebrospinal Fluid by Targeted Mass Spectrometry at High Sequence Coverage Provides Insights into Its Primary Structure Heterogeneity.

The prognostic value of the Tau protein serum level in metastatic breast cancer patients and its correlation with brain metastases

Towards a routine application of Top-Down approaches for label-free discovery workflows

[CSF biomarkers: proteomics investigations and clinical applications in neurodegenerative disorders]